Table 1. Non Small Cell Lung Cancer Treatment Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Non Small Cell Lung Cancer Treatment Market Restraints

Table 3. Non Small Cell Lung Cancer Treatment Market Trends

Table 4. Non Small Cell Lung Cancer Treatment Industry Policy

Table 5. Global Non Small Cell Lung Cancer Treatment Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Non Small Cell Lung Cancer Treatment Revenue Share by Company, 2019-2024, Ranked by Data of 2022

Table 7. Global Non Small Cell Lung Cancer Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Non Small Cell Lung Cancer Treatment Mergers & Acquisitions, Expansion Plans

Table 9. Global Non Small Cell Lung Cancer Treatment Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Non Small Cell Lung Cancer Treatment Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 12. China Non Small Cell Lung Cancer Treatment Revenue Market Share by Company, 2019-2024

Table 13. Global Key Players of Non Small Cell Lung Cancer Treatment Upstream (Raw Materials)

Table 14. Global Non Small Cell Lung Cancer Treatment Typical Customers

Table 15. Non Small Cell Lung Cancer Treatment Typical Distributors

Table 16. By Type, Global Non Small Cell Lung Cancer Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Application, Global Non Small Cell Lung Cancer Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 19. By Region, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Table 20. By Country, Global Non Small Cell Lung Cancer Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 21. By Country, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Table 22. By Country, Global Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2019-2030

Table 23. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 24. Novartis AG Company Profile and Main Business

Table 25. Novartis AG Non Small Cell Lung Cancer Treatment Models, Specifications, and Application

Table 26. Novartis AG Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, US$ Million, 2019-2024

Table 27. Novartis AG Recent Developments

Table 28. Pfizer Inc Company Information, Head Office, Market Area and Industry Position

Table 29. Pfizer Inc Company Profile and Main Business

Table 30. Pfizer Inc Non Small Cell Lung Cancer Treatment Models, Specifications, and Application

Table 31. Pfizer Inc Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, US$ Million, 2019-2024

Table 32. Pfizer Inc Recent Developments

Table 33. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 34. Sanofi Company Profile and Main Business

Table 35. Sanofi Non Small Cell Lung Cancer Treatment Models, Specifications, and Application

Table 36. Sanofi Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, US$ Million, 2019-2024

Table 37. Sanofi Recent Developments

Table 38. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position

Table 39. F. Hoffmann-La Roche Ltd Company Profile and Main Business

Table 40. F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Models, Specifications, and Application

Table 41. F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, US$ Million, 2019-2024

Table 42. F. Hoffmann-La Roche Ltd Recent Developments

Table 43. Astrazeneca Company Information, Head Office, Market Area and Industry Position

Table 44. Astrazeneca Company Profile and Main Business

Table 45. Astrazeneca Non Small Cell Lung Cancer Treatment Models, Specifications, and Application

Table 46. Astrazeneca Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, US$ Million, 2019-2024

Table 47. Astrazeneca Recent Developments

Table 48. Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position

Table 49. Eli Lilly and Company Company Profile and Main Business

Table 50. Eli Lilly and Company Non Small Cell Lung Cancer Treatment Models, Specifications, and Application

Table 51. Eli Lilly and Company Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, US$ Million, 2019-2024

Table 52. Eli Lilly and Company Recent Developments

Table 53. Merck & Co Inc Company Information, Head Office, Market Area and Industry Position

Table 54. Merck & Co Inc Company Profile and Main Business

Table 55. Merck & Co Inc Non Small Cell Lung Cancer Treatment Models, Specifications, and Application

Table 56. Merck & Co Inc Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, US$ Million, 2019-2024

Table 57. Merck & Co Inc Recent Developments

Table 58. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

Table 59. Bristol-Myers Squibb Company Company Profile and Main Business

Table 60. Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Models, Specifications, and Application

Table 61. Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, US$ Million, 2019-2024

Table 62. Bristol-Myers Squibb Company Recent Developments

Table 63. Celgene Corporation Company Information, Head Office, Market Area and Industry Position

Table 64. Celgene Corporation Company Profile and Main Business

Table 65. Celgene Corporation Non Small Cell Lung Cancer Treatment Models, Specifications, and Application

Table 66. Celgene Corporation Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, US$ Million, 2019-2024

Table 67. Celgene Corporation Recent Developments

List of Figures

Figure 1. Non Small Cell Lung Cancer Treatment Picture

Figure 2. Global Non Small Cell Lung Cancer Treatment Consumption Value, (US$ million) & (2019-2030)

Figure 3. China Non Small Cell Lung Cancer Treatment Consumption Value, (US$ million) & (2019-2030)

Figure 4. By Consumption Value, China Non Small Cell Lung Cancer Treatment Market Share of Global, 2019-2030

Figure 5. Global Non Small Cell Lung Cancer Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 6. China Non Small Cell Lung Cancer Treatment Key Participants, Market Share, 2022

Figure 7. Non Small Cell Lung Cancer Treatment Industry Chain

Figure 8. Non Small Cell Lung Cancer Treatment Procurement Model

Figure 9. Non Small Cell Lung Cancer Treatment Sales Model

Figure 10. Non Small Cell Lung Cancer Treatment Sales Channels, Direct Sales, and Distribution

Figure 11. Chemotherapy

Figure 12. Targeted Therapy

Figure 13. Immunotherapy

Figure 14. By Type, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 15. By Type, Global Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2019-2030

Figure 16. Hospital

Figure 17. Clinic

Figure 18. Others

Figure 19. By Application, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 20. By Application, Global Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2019-2030

Figure 21. By Region, Global Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2019-2030

Figure 22. North America Non Small Cell Lung Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 23. By Country, North America Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022

Figure 24. Europe Non Small Cell Lung Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 25. By Country, Europe Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022

Figure 26. Asia Pacific Non Small Cell Lung Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 27. By Country/Region, Asia Pacific Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022

Figure 28. South America Non Small Cell Lung Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 29. By Country, South America Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022

Figure 30. Middle East & Africa Non Small Cell Lung Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 31. U.S. Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 32. By Type, U.S. Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 34. Europe Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 35. By Type, Europe Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 36. By Application, Europe Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 37. China Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 38. By Type, China Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 39. By Application, China Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 40. Japan Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 41. By Type, Japan Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 42. By Application, Japan Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 43. South Korea Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 44. By Type, South Korea Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 45. By Application, South Korea Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 46. Southeast Asia Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 47. By Type, Southeast Asia Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 48. By Application, Southeast Asia Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 49. India Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 50. By Type, India Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 51. By Application, India Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 52. Middle East & Africa Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030, US$ Million

Figure 53. By Type, Middle East & Africa Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 54. By Application, Middle East & Africa Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2022 VS 2029

Figure 55. Research Methodology

Figure 56. Breakdown of Primary Interviews

Figure 57. Bottom-up and Top-down Approaches

Figure 58. Top-down Approaches